Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Japan flag Japan · Delayed Price · Currency is JPY
5,830.00
+74.00 (1.29%)
At close: Feb 27, 2026
4.03%
Market Cap 433.40B
Revenue (ttm) 165.74B
Net Income (ttm) 3.66B
Shares Out 74.34M
EPS (ttm) 49.18
PE Ratio 118.54
Forward PE 32.92
Dividend 106.00 (1.82%)
Ex-Dividend Date Dec 29, 2025
Volume 222,300
Average Volume 229,790
Open 5,771.00
Previous Close 5,756.00
Day's Range 5,762.00 - 5,839.00
52-Week Range 4,850.00 - 5,885.00
Beta 0.29
RSI 68.91
Earnings Date Feb 10, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling g... [Read more]

Founded 1886
Employees 3,615
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4967
Full Company Profile

Financial Performance

In 2025, Kobayashi Pharmaceutical's revenue was 165.74 billion, an increase of 0.09% compared to the previous year's 165.60 billion. Earnings were 3.66 billion, a decrease of -63.68%.

Financial Statements

News

There is no news available yet.